FDA Approves Unknown Drug — HIKMA
HIKMA announced the FDA approval of a **mitsubishiTanabe** manufactured injectable product under ANDA 085432. This new addition to the company's portfolio strengthens its core generic injectables franchise, offering an additional revenue stream as the firm continues to execute its launch strategy.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed